spasticity 的治疗方法
Jonathan Marsden1, Valerie Stevenson2, Louise Jarrett3
1School of Health Professions, Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
Handbook of clinical neurology
|August 24, 2023
概括
性涉及增加拉伸反射活动,并可能导致运动问题. 了解其原因是有效管理的关键,指导物理,药物或手术干预之间的选择.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
背景情况:
- 性是一种运动障碍,其特点是伸展反射刺激性增加和肌肉过度活跃.
- 它表现为积极的迹象 (克隆,) 和消极的迹象 (,体位控制受损).
- 性在损伤后发展,影响运动速度,协调,并引起疼痛.
研究的目的:
- 阐明性和高血压的病理生理学.
- 突出区分神经硬度与被动硬度在治疗选择中的重要性.
- 概述一种以患者为中心的多学科方法来治疗性.
主要方法:
- 综述的潜在机制,包括下行道损伤,脊柱抑制变化和运动神经元适应.
- 讨论导致高血压的被动因素,例如肌肉组织特性变化.
- 强调全面的患者评估,包括触发因素和个人目标.
主要成果:
- 性是由复杂的神经和适应性变化引起的.
- 区分神经和被动是指导干预的关键.
- 管理策略是根据个体患者的因素和性特征量身定制的.
结论:
- 有效的性管理需要对其原因和患者特定需求有充分的了解.
- 有一系列的干预措施,从物理治疗和口服药物到焦点治疗和手术.
- 多学科评估和以患者为中心的目标对于优化结果至关重要.
相关概念视频
Spasmolytic Agents: Chemical Classification
916
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
916
Centrally Acting Muscle Relaxants: Therapeutic Uses
727
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
727
Skeletal Muscle Relaxants: Therapeutic Uses
511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703


